Starting the Conversation: HIV Testing and Initiating PrEPPremiere Date: Monday, April 4, 2022
This activity will offer CE credit for:
- Pharmacy (acpe)
All other clinicians will receive a Certificate of Attendance stating this activity was certified for AMA PRA Category 1 Credit™
Credit Expiration Date:
Tuesday, April 4, 2023
Note: Credit Is No Longer Available
|Dan Scales, PharmD, AAHIVP (Moderator)
Director of Pharmacy Collaborative Care
|Kalumi Ayala-Rivera, PharmD, AAHIVP, TTS
Clinical Assistant Professor
Pharmacy Practice Department
Nova Southeastern University, College of Pharmacy
PR Regional Campus
HIV Clinical Pharmacist at Centro Ararat
The majority of HIV pre-exposure prophylaxis (PrEP) curricula in PharmD programs teach information consistent with HIV prevention treatment guidelines. However, in a 2021 survey, a vast majority (> 75%) of learners, primarily pharmacists, were not confident about providing HIV PrEP counseling to patients, and more than 50% indicated that they needed additional education on creating an environment where patients seeking HIV prevention guidance feel more welcome.
In the final episode of this CMEO podcast series, Starting the Conversation: HIV Testing & Initiating PrEP, join Drs. Dan Scales and Kalumi Ayala-Rivera as they provide valuable guidance on engaging at-risk patients in informed and sensitive discussions regarding HIV testing and initiation of PrEP.
At the end of this CE activity, participants should be able to:
- Implement sensitive and appropriate patient education regarding HIV testing and HIV PrEP with patients at risk for HIV.
Supported by an educational grant from Gilead Sciences, Inc. This educational activity is supported by an independent educational grant from ViiV Healthcare. ViiV Healthcare was not involved in the developmental content or selection of faculty for this educational activity.
Specific CE Credit information is not available at this time. Please check again soon!
It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and attempted to resolve any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.
Dr. Scales reports no financial relationships.
Dr. Ayala-Rivera reports the following financial relationships:
Advisory Board: Post IAS Regional East Advisory Board for ViiV Healthcare
The following peer reviewer and CME Outfitters staff have no financial relationships:
Faculty of this CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices.
Questions about this activity? Call us at 877.CME.PROS (877.263.7767).